Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 18/20 | 0.46 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.38 |
| ▸ | NPY2R | P49146 | 1/20 | 0.38 |
| ▸ | NPY4R | P50391 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29625209 | 0.93 | ENPEP (0.48) | ENPEP | |
| SCHEMBL30092240 | 0.93 | ENPEP (0.49) | ENPEP | |
| SCHEMBL31491259 | 0.91 | ENPEP (0.46) | ENPEP | |
| SCHEMBL30692438 | 0.90 | TASP1 (0.49) | VIPR1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30423080 | 0.89 | NPY4R (0.40) | ENPEPNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29604474 | 0.88 | ENPEP (0.44) | ENPEPNPY4R | |
| SCHEMBL31013475 | 0.88 | SIRT2 (0.43) | VIPR1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31013467 | 0.88 | SIRT2 (0.43) | VIPR1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL19554383 | 0.87 | NPY4R (0.39) | ENPEPNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29416160 | 0.87 | TASP1 (0.49) | VIPR1NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11860174-B2 | Anti-cannabidiol antibody and uses thereof | Bomi LLC (US) | 2024-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11860174-B2 | Anti-cannabidiol antibody and uses thereof | CNR2, CNR1, MAG | ENPEP 1556/4885VIPR1 3011/4885NPY1R 1503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.